SEC Form 4 · accession 0001179110-16-018453
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John C Martin
Officer — Chairman and CEO · Director
Period of report
Feb 1, 2016
Accepted (ET)
Feb 3, 2016 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2016 | M | 100,000 | $16.395 | A | 4,048,066 | D | |
| Common StockF4 | Feb 1, 2016 | S | 43,627 | $82.9795 | D | 4,004,439 | D | |
| Common StockF5 | Feb 1, 2016 | S | 55,973 | $83.7652 | D | 3,948,466 | D | |
| Common StockF6 | Feb 1, 2016 | S | 400 | $84.3475 | D | 3,948,066 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock option (right to buy)F2 | $16.395 | Feb 1, 2016 | M | 100,000 | D | — | Jan 22, 2017 | Common Stock | 100,000 | 1,000,000 | D |
| Non-Qualified Stock option (right to buy)F3 | $84.05 | Feb 1, 2016 | A | 128,630 | A | — | Feb 1, 2026 | Common Stock | 128,630 | 128,630 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- F3The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- F4Sale prices reported for the transactions reported here range from $82.31 to $83.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F5Sale prices reported for the transactions reported here range from $83.32 to $84.30. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F6Sale prices reported for the transactions reported here range from $84.33 to $84.38. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.